Takai Shinji | Department Of Animal Hygiene School Of Veterinary Medicine And Animal Sciences Kitasato University
スポンサーリンク
概要
- TAKAI Shinjiの詳細を見る
- 同名の論文著者
- Department Of Animal Hygiene School Of Veterinary Medicine And Animal Sciences Kitasato Universityの論文著者
関連著者
-
MIYAZAKI Mizuo
Department of Pharmacology, Osaka Medical College
-
Takai Shinji
Department Of Cardiology Kouseikai Takeda Hospital
-
JIN Denan
Department of Pharmacology, Osaka Medical College
-
Sawada Takahisa
京都第一赤十字病院 循環器科
-
Tanaka Shiro
大阪市立総合医療センター
-
Tanaka Shiro
Department Of Internal Medicine Osaka City General Hospital
-
Sakaguchi Minoru
大阪薬科大学
-
Sakaguchi Minoru
Intensive Grazing Research Team National Agricultural Research Center For Hokkaido Region National A
-
Takai S
Department Of Pharmacology Osaka Medical College
-
Kato Tomoko
国立循環器病研究センター 心臓血管内科部門
-
Katsuoka Y
大阪医科大学 泌尿器科学
-
Yamasaki Kazuhiro
Institute For Health Care Science Suntory Ltd.
-
Hanafusa Toshiaki
Department Of First Internal Medicine Osaka Medical College
-
Takai Shinji
Department Of Cardiovascular Medicine Kyoto Prefectural University School Of Medicine
-
Matsubara Hiroaki
Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine
-
Nishimoto Masayoshi
Department of Emegency Medicine, Osaka Mishima Emergency and Critical Care Center
-
Okigaki Mitsuhiko
Department Of Cardiovascular Medicine Kyoto Prefectural University Of Medicine
-
Hayashi T
Third Dep. Of Medicine Osaka Medical Coll. Jpn
-
Hayashi Tetsuya
大阪医科大学 薬理学教室
-
Matsubara Hiroaki
Department Of Cardiology Kyoto Prefectural University Of Medicine
-
ANDO Katsuyuki
University of Tokyo
-
Amano Katsuya
University Of Tokyo
-
Amano Katsuya
Department Of Cardiovascular Medicine Kyoto Prefectural University School Of Medicine
-
Hayashi Tetsuya
Third Department of Internal Medicine, Osaka Medical College
-
Okigaki Mitsuhiko
京都府立医科大学 循環器･腎臓内科学
-
TANAKA Kazuhiko
Department of Clinical Pharmacology & Pharmacokinetics, Osaka University of Pharmaceutical Sciences
-
Iwasaka Toshiji
Department of Medicine 2 Kansai Medical University
-
Kurihara Hirohiko
National Defense Medical College
-
Kitaura Y
Department Of Internal Medicine Iii Osaka Medical College
-
Kita Yoshio
大阪医科大学 第3内科
-
Kitaura Yasushi
Third Department Of Internal Medicine Osaka Medical College
-
YOKOYAMA Mitsuhiro
Division of Cardiovascular and Respiratory Medicine, Department of Internal Medicine, Kobe Universit
-
Amano Katsuya
Department of Cardiovascular Medicine, Kyoto Prefectural University School of Medicine
-
Okigaki Mitsuhiko
Department of Cardiovascular Medicine, Kyoto Prefectural University School of Medicine
-
Kitaura Y
Third Department Of Internal Medicine Osaka Medical College
-
Mori Yasukiyo
Cardiovascular Division Department Of Medicine Ii Kansai Medical University
-
Mori Yasukiyo
Department of Cardiovascular Medicine, Kyoto Prefectural University School of Medicine
-
Koito Hitoshi
The Cardiovascular Center Kansai Medical University
-
Ishihara Tadashi
First Department of Internal Medicine, Osaka Medical College
-
Kitaura Yasushi
Department Of Cardiovascular Science And Medicine Chiba University Graduate School Of Medicine
-
Yokoyama Mitsuhiro
Division Of Cardiovascular And Respiratory Medicine Department Of Internal Medicine Kobe University
-
Kitaura Yasushi
大阪医科大学 3内
-
Kawashima Seinosuke
Division Of Cardiovascular And Respiratory Medicine Kobe University Graduate School Of Medicine
-
Inoue Nao
Department of Cardiology, Juntendo University School of Medicine
-
TAMAI Hiroshi
Department of Pediatrics, Osaka Medical College
-
Iwasaka Toshiji
The Cardiovascular Center Kansai Medical University
-
Kitaura Yasushi
Third Department Of Medicine Osaka Medical College
-
KISHI Kanta
Department of Pediatric Cardiology, Heart Institute, Tokyo Women's Medical University
-
Kishi Kanta
Department Of Pharmacology Osaka Medical College
-
Kishi Kanta
Department Of Pediatric Cardiology Heart Institute Tokyo Women's Medical University
-
Yamada Mayumi
Department of Cardiology, Kyorin University School of Medicine
-
Kihara Yasuki
Kobe General City Hospital
-
Mori Yasukiyo
京都府立医科大学 循環器内科学
-
Yamada M
Department Of Pharmacology Osaka Medical College
-
Yamada Mayumi
Department Of Cardiology Kyorin University School Of Medicine
-
Sawada Takahisa
Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine
-
KUMAGAI Hiroo
National Defense Medical College
-
Sakamoto Kenji
熊本大学 医学教育部循環器病態学
-
OKAMOTO Ryoichi
Department of Microbiology, Kitasato University School of Medicine
-
Koide Shunichi
熊本大学 循環器内科
-
AZUMA Akihiro
Department of Cardiology, National Shiga Hospital
-
Hoshiga Masaaki
First Department of Internal Medicine, Osaka Medical College
-
Kitaura Y
Third Department Of Medicine Osaka Medical College
-
Ukimura Akira
Department Of Internal Medicine Iii Osaka Medical College
-
Makino H
Department Of Medicine And Clinical Science Okayama University Graduate School Of Medicine And Denti
-
Masaki Hiroya
The Cardiovascular Center Kansai Medical University
-
SOHMIYA Koichi
Third Department of Internal Medicine, Osaka Medical College
-
Kudoh Sumiyo
Department Of Internal Medicine Iii Osaka Medical College
-
Sohmiya Koichi
Department Of Internal Medicine Iii Osaka Medical College
-
Sohmiya Koichi
Third Department Of Internal Medicine Osaka Medical College
-
Ukimura Akira
Third Department Of Internal Medicine Osaka Medical College
-
Kitaura Yasushi
大阪医科大学 薬理学教室
-
Kawashima Seinosuke
Department Of General Medicine Nakatsu Saiseikai Hospital
-
Zen Kan
Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine
-
Takamiya Michitaka
Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine
-
Azuma A
Department Of Cardiology National Shiga Hospital
-
Azuma Akihiro
松下電器健康保険組合松下記念病院
-
Kawakami Yoshihide
大阪医科大学 第3内科
-
Takeda Yoshihiro
Department Of First Internal Medicine Osaka Medical College
-
HANAFUSA Toshiaki
First Department of Internal Medicine, Osaka Medical College
-
Zen Kan
Department Of Cardiovascular Medicine Kyoto Prefectural University Of Medicine
-
YUKI Takahito
Department of First Internal Medicine, Osaka Medical College
-
Fujisaka Tomohiro
First Department of Internal Medicine, Osaka Medical College
-
Yuki Takahito
First Department of Internal Medicine, Osaka Medical College
-
Takeda Yoshihiro
First Department of Internal Medicine, Osaka Medical College
-
Kohbayashi Eiko
First Department of Internal Medicine, Osaka Medical College
-
Takaoka Masanori
Department Of Internal Medicine Iii Osaka Medical College
-
Teragaki M
Department Of Internal Medicine And Cardiology Osaka City University Graduate School Of Medicine
-
Kobayashi Seiichi
神戸大学 院循環呼吸器病態学
-
Hocchi Junko
Department Of First Internal Medicine Osaka Medical College
-
Yuki Takahito
Department Of First Internal Medicine Osaka Medical College
-
Katsuoka Yoji
Department Of Urology Osaka Medical College
-
TAKAO Kazumasa
Department of Pharmacology, Osaka Medical College
-
IMAI Yumiko
Department of Biological Informatics and Experimental Therapeutics, the Global COE program, Akita Un
-
SUGIYAMA Tetsuya
Department of Removable Prosthodontics and Gerodontology, Tokyo Dental College
-
KAJIMOTO Yoshinaga
Department of Neurosurgery, Osaka Medical College
-
Morikawa Takashi
Department of Internal Medicine, Osaka City General Hospital
-
Yoshioka Katsunobu
Department of Internal Medicine, Osaka City General Hospital
-
FUJITA Tadashi
Department of Orthodontics and Craniofacial Developmental Biology, Hiroshima University, Graduate Sc
-
HORIO Takeshi
National Cardiovascular Center
-
TANAKA Hidekazu
Department of Natural History Sciences, Faculty of Science, Hokkaido University
-
Tsutsumi Yoshiaki
Department of Cardiovascular Medicine, National Cardiovascular Center
-
IKEDA Tadashi
Department of Surgery, Keio University School of Medicine
-
Yoshida Kaoru
Department Of Cardiology Kawasaki Medical School
-
IRIE Hidekazu
Department of Cardiology, Kouseikai Takeda Hospital
-
Iwasaka Toshiji
Cardiovascular Division, Department of Medicine II, Kansai Medical University
-
Zushi Ryousuke
Department of Emegency Medicine, Osaka Mishima Emergency and Critical Care Center
-
Hazui Hiroshi
Department of Emegency Medicine, Osaka Mishima Emergency and Critical Care Center
-
Mori Toshizumi
Department of Emegency Medicine, Osaka Mishima Emergency and Critical Care Center
-
Ohishi Yasuo
Department of Emegency Medicine, Osaka Mishima Emergency and Critical Care Center
-
Yamamoto Hiromi
Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University
-
KISO Yoshinobu
Institute for Health Care Science, Suntory Ltd.
-
Tsutsumi Yoshiaki
Division Of Cardiology National Cardiovascular Center
-
komeda Masashi
Department of Cardiovascular Surgery, Kyoto University
-
MIYATAKE Shin-Ichi
Department of Neurosurgery, Osaka Medical College
-
KUROIWA Toshihiko
Department of Neurosurgery, Osaka Medical College
-
Matsubara Hiroaki
公立南丹病院 循環器内科
-
Kitaura Yasushi
Third Department of Internal Medicine, Osaka Medical College
-
UKIMURA Akira
Third Department of Internal Medicine, Osaka Medical College
-
Mori Tatsuhiko
Third Department of Medicine, Osaka Medical College
-
IKEDA Tsunehiko
Department of Internal Medicine 2, Fukushima Medical University School of Medicine
-
Kamihata Hiroshi
Department of Cardiology, Kansai Medical University Hospital
-
Ukimura Akira
Department Of Cardiology Shiga Medical Center For Adult Diseases
-
KOZAWA Osamu
Department of Pharmacology, Gifu University Graduate School of Medicine
-
Takahashi Hakuo
Department Of Clinical Sciences And Laboratory Medicine Kansai Medical University
-
Takahashi Hakuo
Department Of Cardiovascular Medicine Shinshu University Graduate School Of Medicine
-
OKADA Noriyuki
Department of Kidney Disease and Hypertension, Osaka General Medical Center
-
Okada Noriyuki
Department Of Nephrology And Hypertension Osaka City General Hospital
-
Okada Noriyuki
大阪市立総合医療センター 内科
-
Yokoyama Mitsuhiro
富山大学 医学部バイオ統計学臨床疫学
-
UEDA Makiko
Department of Pathology, Osaka City University Graduate School of Medicine
-
Kitaura Yasushi
Third Division Department Of Internal Medicine Osaka Medical College
-
Nozawa Yoshihisa
Pharmacobioregulation Research Laboratory Hanno Research Center
-
Hiroe Michiaki
Department Of Medicine Tokyo Medical And Dental University
-
Kitabayashi Chizuko
Department of Pathology, Osaka City University Graduate School of Medicine
-
NISHIYAMA Akira
Department of Pharmacology, Kagawa Medical University
-
Azuma Akihiro
康生会武田病院 循環器科
-
Matsumura E
大阪医科大学 薬理
-
Metoki Hirohito
東北大学 臨床薬学
-
OKA Yuko
Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science
-
Mori Toshizumi
Department Of Emegency Medicine Osaka Mishima Emergency And Critical Care Center
-
Ueda Makiko
Department Of Pathology Osaka City University Graduate School Of Medicine
-
Kitabayashi Chizuko
Department Of Pathology Osaka City University Graduate School Of Medicine
-
Zushi Ryousuke
Department Of Emegency Medicine Osaka Mishima Emergency And Critical Care Center
-
Konishi Yoshio
Department of Internal Medicine, Osaka City General Hospital
-
Imanishi Masahito
Department of Internal Medicine, Osaka City General Hospital
-
Tanaka Shiro
Department Of Pharmacology Osaka Medical College
-
Imanishi Masahito
Department Of Nephrology And Hypertension Osaka City General Hospital
-
Imanishi Masahito
Department Of Internal Medicine
-
FUKUMOTO Masanori
Department of Ophthalmology, Osaka Medical College
-
OKU Hidehiro
Department of Ophthalmology, Osaka Medical College
-
Harada Atsushi
Department of CCU and Medicine, Nippon Medical School
-
Yoshida Kiyoshi
Division Of Cardiology Kawasaki Medical School
-
Yoshida K
Department Of Internal Medicine And Cardiology Osaka Ekisaikai Hospital
-
Okigaki Mitsuhiko
Division Of Hypertension And Nephrology Department Of Internal Medicine Kyoto Prefectural University
-
YAMASHITA Chika
Laboratory of Pathological and Molecular Pharmacology, Osaka University of Pharmaceutical Sciences
-
MIYAMURA Masatoshi
Department of Internal Medicine III, Osaka Medical College
-
MORI Tatsuhiko
Department of Internal Medicine III, Osaka Medical College
-
MATSUMOTO Chika
Laboratory of Pathological and Molecular Pharmacology, Osaka University of Pharmaceutical Sciences
-
HAYASHI Tetsuya
Department of Internal Medicine III, Osaka Medical College
-
Yamauchi Kazunobu
The First Department Of Internal Medicine Nagoya University School Of Medicine
-
MARUYAMA Katsuya
Department of Internal Medicine, Kurihama National Hospital
-
Hotchi Junko
First Department of Internal Medicine, Osaka Medical College
-
Hoshiga Masaaki
1st Department of Internal Medicine, Osaka Medical College
-
Hanafusa Toshiaki
1st Department of Internal Medicine, Osaka Medical College
-
Hocchi Junko
First Internal Medicine, Osaka Medical College
-
Okabe Taichi
First Internal Medicine, Osaka Medical College
-
Ishihara Tadashi
1st Department of Internal Medicine,Osaka Medical College
-
Arishiro Kumiko
1st Department of Internal Medicine, Osaka Medical College
-
Nariyama Jin
Department of Cardiology, Osaka Railway Hospital
-
Miyamoto Hiroyuki
1st Department of Internal Medicine, Osaka Medical College
-
Gotou Takuya
Department of emergency medicine, Osaka Mishima Emegency and Critical Care Center
-
Fukumoto Hitoshi
Department of Emergency Medicine, Osaka Mishima Emergency and Critical Care Center
-
Negoro Nobuyuki
The First Department of Internal Medicine, Osaka Medical College
-
Kohbayashi Eiko
The First Department of Internal Medicine, Osaka Medical College
-
Muraoka Hideyuki
Osaka Mishima Emergency and Critical Care Medical Center
-
Hoshiga Masaaki
The First Department of Internal Medicine, Osaka Medical College
-
Ishihara Tadashi
The First Department of Internal Medicine, Osaka Medical College
-
Hanafusa Toshiaki
The First Department of Internal Medicine, Osaka Medical College
-
Nariyama Jin
The First Department of Internal Medicine, Osaka Medical College
-
Okabe Taichi
The First Department of Internal Medicine, Osaka Medical College
-
Arishiro Kumiko
The First Department of Internal Medicine
-
Nakakohji Takahiro
The First Department of Internal Medicine
-
OKAMOTO Ken
Department of Surgery, Kochi Medical School
-
前島 一淑
慶應義塾大学医学部動物実験センター
-
前島 一淑
慶應義塾大学医学部
-
前島 一淑
慶応義塾大学 医・動物実験センター
-
前島 一淑
慶応大学医学部動物実験施設
-
Matsubara Hiroaki
Cardiovascular Division Department Of Medicine Ii Kansai Medical University
-
Matsumura Eiko
大阪医科大学 薬理
-
OKUMURA Michiaki
Department of Internal Medicine
-
Nariyama Jin
Department Of Cardiology Osaka Railway Hospital
-
Kayama Yosuke
千葉大学 循環病態医科学
-
Komeda M
Department Of Cardiovascular Surgery Kyoto University Graduate School Of Medicine
-
Komeda Masashi
京都大学 医研究 循環病態
-
Komeda Masashi
Department Of Cardiovascular Surgery Graduate School Of Medicine Kyoto University
-
MAEDA Isseki
Department of Internal Medicine, Osaka City General Hospital
-
Takahashi Hakuo
Department Of Cardiology Rakusai Newtown Hospital Kansai Medical University
-
ISHIHARA Takafumi
Discovery Research Division, Santen Pharmaceutical Co., Ltd.
-
MITA Shiro
Discovery Research Division, Santen Pharmaceutical Co., Ltd.
著作論文
- New Approaches to Blockade of the Renin–Angiotensin–Aldosterone System: Chymase as an Important Target to Prevent Organ Damage
- Long-Term Angiotensin II Blockade May Improve Not Only Hyperglycemia but Also Age-Associated Cardiac Fibrosis
- PE-354 Aortic Valve Thickness Depends on Cardiac ACE Activity, not Blood Pressure in 1K-, 1K1C-, and 2K1C-Rabbit Models(PE060,Valvular Heart Disease (M),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- OE-235 Evidence of Plaque Neovascularization and Effects of Angiotensin Receptor Blocker in Cholesterol-Fed Monkey(OE40,Atherosclerosis, Basic 2 (IHD),Oral Presentation (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- OE-307 Imidapril Attenuates MMP-9 Level More Effectively than Losartan in Patients with Acute Myocardial Infarction Treated by Primary-Percutaneous Coronary Intervention(Acute myocardial infarction, clinical(diagnosis/treatment)(02)(IHD),Oral Presentation
- PE-317 Angiotensin Receptor 1 Blocker Inhibits Atherosclerotic Changes of Aortic Valve by Preserving Endothelial Cells and Inhibiting Transformation into Osteoblast Phenotype(Vascular heart disease/Pericarditis/Cardiac tumor-2 (M) PE53,Poster Session (Eng
- Evidence for Abundant Presence of Chymase-Positive Mast Cells in the Kidneys of Patients with Immunoglobulin A Nephropathy : Effect of Combination Therapy with Prednisolone and Angiotensin II Receptor Blocker Valsartan
- Inhibition of Human Chymase by Suramin
- Angiotensin II Type 1 Receptor Antagonist, TCV-1 16, Prevents Neointima Formation in Injured Arteries in the Dog
- IS005 Vascular Smooth Muscle Cell(VSMC)-Specific Overexpression of Angiotensin type2(AT2)Receptor Causes Endothelium-dependent Vasodilation via bradykinin/NO/cGMP pathway
- Inhibition of the Angiotensin II Type 1 Receptor by TCV-116: Quantitation by In Vitro Autoradiography
- P218 INTERACTION OF VASCULAR SMOOTH MUSCLE CELLS(VSMC) WITH EXTRACELLULAR MATRIX(ECM) : EFFECTS OF THE PURIFIED HUMAN CHYMASE ON VSMC ATTACHMENT TO ECM
- Chymase inhibition attenuates tetrachloride-induced liver fibrosis in hamsters
- Chymase inhibitor prevents the nonalcoholic steatohepatitis in hamsters fed a methionine- and choline-deficient diet
- Significance of angiotensin II receptor blockers with high affinity to angiotensin II type 1 receptors for vascular protection in rats
- Anti-Atherosclerotic Effects of Dihomo-γ-Linolenic Acid in ApoE-Deficient Mice
- Chymase Inhibition Provides Pancreatic Islet Protection in Hamsters With Streptozotocin-Induced Diabetes
- Involvement of Vascular Angiotensin II-Forming Enzymes in the Progression of Aortic Abdominal Aneurysms in Angiotensin II-Infused ApoE-Deficient Mice
- Significance of chymase-dependent angiotensin II formation in the progression of human liver fibrosis
- Characterization of Recombinant Human Chymase Expressed in Escherichia coli
- OJ-062 Effect of Chymase Inhibition by NK-3201 on Hypoxia-Induced Left Ventricular Remodeling in Mice(Cardiovascular pharmacology, basic/clinical(02)(H),Oral Presentation(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- The Significance of Chymase in the Progression of Abdominal Aortic Aneurysms in Dogs
- OJ-199 Role of Chymase and MMPs in Angiotensin II-induced Abdominal Aortic Aneurysms(Atherosclerosis, basic-3, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- The Effects of Chymase on Matrix Metalloproteinase-2 Activation in Neointimal Hyperplasia after Balloon Injury in Dogs
- Tissue Angiotensin II Generating System by Angiotensin-Converting Enzyme and Chymase
- PJ-418 Effects of Chymase Inhibition on the Stenosis after Polytetrafluoroethylene Grafts Implantation(Restenosis, basic/clinical-5 (IHD) PJ71,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
- PE-278 Chymase Inhibition Prevents the Progression of Abdominal Aortic Aneurysm in Dogs(Peripheral circulation-5 (H) PE47,Poster Session (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
- Chymase Inhibition Prevents Cardiac Fibrosis and Dysfunction after Myocardial Infarction in Rats
- Role of Chymase-Dependent Angiotensin II Formation in Regulating Blood Pressure in Spontaneously Hypertensive Rats
- The Effect of Chymase Inhibition on Arteriovenous Fistula Stenosis in Dogs (Peripheral Circulation/Vascular Disease 6 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- A Potent Chymase Inhibitor, Suc-Val-Pro-Phe(p)(OPh)(2), Suppresses the Development of Abdominal Aortic Aneurysm in Dogs(Valvular Heart Disease/Pericarditis/Cardiac Tumor 2 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Effect of Chymase-Dependent Transforming Growth Factor β on Peritoneal Adhesion Formation in a Rat Model
- A Single Treatment With a Specific Chymase Inhibitor, TY-51184, Prevents Vascular Proliferation in Canine Grafted Veins
- PJ-043 An Antiarrhythmic Effect of A Chymase Inhibitor After Myocardial Infarction(Acute Myocardial Infarction, Basic 2 (IHD) : PJ8)(Poster Session (Japanese))
- Impact of Chymase Inhibitor on Cardiac Function and Survival after Myocardial Infarction
- Oral Administration of a Specific Chymase Inhibitor, NK3201, Suppresses the Development of Aneurysmal Dilatation on Hamster Experimental Aneurysm Model
- Possible Roles of Angiotensin II-Forming Enzymes, Angiotensin Converting Enzyme and Chymase-like Enzyme, in the Human Aneurysmal Aorta
- Effect of Chymase Inhibitor on Vascular Proliferation
- Development of the Chymase Inhibitor as an Anti-Tissue-Remodeling Drug : Myocardial Infarction and Some Other Possibilities
- Recombinant Human Chymase Produced by Silkworm-Baculovirus Expression System : Its Application for a Chymase Detection Kit
- Oral Administration of a Novel Chymase Inhibitor, NK3201, Prevents Peritoneal Adhesion Formation in Hamsters
- Inhibition of chymase improves cardiac function via suppression of fibrosis in hamster cardiomyopathic model
- Role of chymase in the development of aneurysmal formation; An experimental aneurysm model
- Beneficial Effects of Angiotensin-Converting Enzyme Inhibition in Adriamycin-Induced Cardiomyopathy in Hamsters
- Possible Roles of Cardiac Chymase After Myocardial Infarction in Hamster Hearts
- An Orally Active Chymase Inhibitor, BCEAB, Suppresses Heart Chymase Activity in the Hamster
- The Functional Ratio of Chymase and Angiotensin Converting Enzyme in Angiotensin I-Induced Vascular Contraction in Monkeys, Dogs and Rats
- Potentiation by platelet-derived growth factor-BB of FGF-2-stimulated VEGF release in osteoblasts
- Trans-Differentiation of Bone Marrow Monocyte-Lineage Cells to Endothelial-Like Cells and Reendothelialization on Injured Endothelium by MCP-1-Dependent Adhesion
- Characteristics of Monkey Tryptase Purified From Cheek Pouch Vascular Tissues
- Raloxifene-Induced Acceleration of Platelet Aggregation
- PE-398 Nuclear Factor-κ B Activation Accelerates Cardiac Hypertrophy, Interstitial Fibrosis, and Oxidative Stress in Diabetic Rats Exposed to Intermittent Hypoxia(Chronic coronary heart disease/Remodeling-2, The 71st Annual Scientific Meeting of the Japan
- G-CSF Treatment Inhibits Neointimal Hyperplasia Associated with Endothelial Progenitor Cell Mobilization and Acceleration of Reendothelialization in Catorid Artery Injuty Model(Restenosis after Angioplasty, Basic/Clinical 5 (IHD), The 69th Annual Scientif
- Critical Role of Tyrosine Kinase PYK2 in eNOS Activation Revealed by Analysis of PYK2 Knockout Mice(Endothelium/NO 5 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- OJ-417 Tyrosine Kinase PYK2 activates eNOS and subsequently regulates Vascular Tonus and Angiogenesis, revealed by its Knock-out Mice(Endothelium/NO 5 (H) : OJ51)(Oral Presentation (Japanese))
- eNOS Activation and Its Vascular Functions Critically Requires the Presence of Tyrosine Kinase PYK2
- OJ-028 G-CSF Treatment Inhibits Neointimal Formation after Arterial Injury through the Mobilization of Endothelial Progenitor Cell and Acceleration of Reendothelialization(Restenosis, basic/clinical-1 (IHD) OJ5,Oral Presentation (Japanese),The 70th Annive
- Inhibition of Vascular Angiotensin-Converting Enzyme by Telmisartan via the Peroxisome Proliferator-Activated Receptor γ Agonistic Property in Rats
- Inhibition of Matrix Metalloproteinase-9 Activity by Trandolapril after Middle Cerebral Artery Occlusion in Rats
- 我が国における子馬のロドコッカス・エクイ感染症の疫学調査--1992年から1998年の108症例
- Trandolapril Reduces Infarction Area after Middle Cerebral Artery Occlusion in Rats
- Effects of a Lipoxygenase Inhibitor, Panaxynol, on Vascular Contraction Induced by Angiotensin II
- SOME EXPERIMENTS ON ASCENDING OF CORYNEBACTERIUM RENALE IN MICE FROM URINARY BLADDER INTO KIDNEYS
- ISOLATION OF NON-PILIATED CLONE OF CORYNEBACTERIUM RENALE STRAIN 115
- Significance of Angiotensin II Receptor Blocker Lipophilicities and Their Protective Effect against Vascular Remodeling
- Combination therapy with irbesartan and efonidipine for attenuation of proteinuria in Dahl salt-sensitive rats
- Genotypic Characterization of Virulent Rhodococcus equi Isolated from the Environment of Hokkaido Native Horses in Hakodate, Hokkaido
- Comparative Effects of Candesartan and Amlodipine in a Monkey Atherosclerotic Model
- Significant Target Organs for Hypertension and Cardiac Hypertrophy by Angiotensin-Converting Enzyme Inhibitors
- Significance of Vascular Angiotensin-Converting Enzyme in the Depressor Mechanism by Angiotensin-Converting Enzyme Inhibitors
- Pharmacological Profiles of a Novel Non-peptide Angiotensin II Type I Receptor Antagonist HR720 In Vitro and In Vivo
- Cloning and Characterization of the fur Gene From Moraxella bovis
- Expression of Virulence-Associated Antigens of Rhodococcus equi Is Regulated by Temperature and pH
- Rhodococcus qui Infection in Foals -Current Concepts and Implication for Future Research-
- VapB-positive Rhodococcus equi infection in an HIV-infected patient in Japan
- Irbesartan Prevents Metabolic Syndrome in Rats via Activation of Peroxisome Proliferator-Activated Receptor γ
- New Approaches to Blockade of the Renin-Angiotensin-Aldosterone System : Chymase as an Important Target to Prevent Organ Damage
- Antiatherosclerotic Effect of Alacepril, an Angiotensin : Converting Enzyme Inhibitor, in Monkeys Fed a High-Cholesterol Diet
- ADHESION OF PILIATED CORYNEBACTERIUM RENALE TO BOVINE BLADDER EPITHELIAL CELLS WITH SPECIAL REFERENCE TO pH DEPENDENCY
- Irbesartan Prevents Metabolic Syndrome in Rats via Activation of Peroxisome Proliferator-Activated Receptor γ
- Multiple Mechanisms for the Action of Chymase Inhibitors
- Serum Levels of Matrix Metalloproteinase (MMP) 9, a Risk Factor for Acute Coronary Syndrome, Are Reduced Independently of Serum MMP-3 by Anti-TNF-α Antibody (Infliximab) Therapy in Patients With Rheumatoid Arthritis
- Outside Fibroblasts Play a Key Role in the Development of Inner Neointima After the Implantation of Polytetrafluoroethylene Grafts
- Serum Levels of Matrix Metalloproteinase (MMP) 9, a Risk Factor for Acute Coronary Syndrome, Are Reduced Independently of Serum MMP-3 by Anti-TNF-α Antibody (Infliximab) Therapy in Patients With Rheumatoid Arthritis
- Quantification of Candesartan in Mouse Plasma by MALDI-TOFMS and in Tissue Sections by MALDI-Imaging Using the Stable-Isotope Dilution Technique
- Significance of Matrix Metalloproteinase-9 Inhibition by Imidapril for Prevention of Abdominal Aortic Aneurysms in Angiotensin II Type 1 Receptor–Knockout Mice
- Significance of the Vascular Concentration of Angiotensin II–Receptor Blockers on the Mechanism of Lowering Blood Pressure in Spontaneously Hypertensive Rats
- Beneficial Effect of Trandolapril on the Lifespan of a Severe Hypertensive Model
- Significance of Vascular Dipeptidyl Peptidase-4 Inhibition on Vascular Protection in Zucker Diabetic Fatty Rats